The NHGRI Sample Repository for Human Genetic Research (NHGRI Repository) offers a growing collection of human induced pluripotent stem cells (iPSCs) and Limited Use Label Licenses (LULLs) may apply.
Human Induced Pluripotent Stem Cell Limited Label Use Licenses
The iPSCs available through the NHGRI Repository have been reprogrammed using technologies licensed by third party entities. Researchers purchasing iPSCs from the NHGRI Repository are responsible for any limited use label licenses (LULLs) applicable to the acquired NHGRI Repository iPSC(s). It is the researcher’s responsibility to investigate whether the intended use of the iPSC requires him/her to obtain commercial technology rights. Below are links to LULLs which may apply to NHGRI Repository iPSCs:
iPS Academia, Japan Inc. License– Licensing policy, as it pertains to the acquisition of iPSCs that make use of reprogramming technologies developed by iPS Academia Japan Inc.
Sendai-CytoTune License – License policy as it pertains to the acquisition of iPSCs that were generated using technology distributed by Thermofisher Scientific.
To obtain rights for the commercial use of Sendai reprogrammed cell lines please contact ID Pharma Co., Ltd. at info@idpharma.jp and Academia Japan, Inc. directly at license@ips-ac.co.jp or through ID Pharma Co., Ltd.
If you have any questions regarding LULLs, please contact the entity holding the license directly.
